Compare LITE & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LITE | EW |
|---|---|---|
| Founded | 2015 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Industrial Specialties |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.1B | 48.9B |
| IPO Year | 2015 | 1999 |
| Metric | LITE | EW |
|---|---|---|
| Price | $869.86 | $90.49 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 21 |
| Target Price | ★ $645.43 | $96.37 |
| AVG Volume (30 Days) | ★ 4.5M | 2.9M |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.07 |
| Revenue | $1,247,700,000.00 | ★ $6,067,600,000.00 |
| Revenue This Year | $79.88 | $13.39 |
| Revenue Next Year | $66.61 | $9.81 |
| P/E Ratio | ★ N/A | $84.80 |
| Revenue Growth | ★ 24.57 | 11.55 |
| 52 Week Low | $133.91 | $72.30 |
| 52 Week High | $1,085.68 | $96.29 |
| Indicator | LITE | EW |
|---|---|---|
| Relative Strength Index (RSI) | 50.49 | 52.00 |
| Support Level | $804.35 | $88.79 |
| Resistance Level | $927.50 | $93.91 |
| Average True Range (ATR) | 62.24 | 1.70 |
| MACD | -0.92 | -0.17 |
| Stochastic Oscillator | 38.68 | 31.55 |
Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.